These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 18022078)

  • 81. De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation.
    Safavi S; Robinson DR; Soresi S; Carby M; Smith JD
    J Heart Lung Transplant; 2014 Dec; 33(12):1273-81. PubMed ID: 25130554
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
    J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.
    Verleden GM; Verleden SE; Vos R; De Vleeschauwer SI; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transpl Int; 2011 Jul; 24(7):651-6. PubMed ID: 21401732
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?
    Jackson CH; Sharples LD; McNeil K; Stewart S; Wallwork J
    J Heart Lung Transplant; 2002 Jun; 21(6):658-66. PubMed ID: 12057699
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakane T; Nakamae H; Kamoi H; Koh H; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Ohta K; Terada Y; Koh KR; Yamane T; Hino M
    Bone Marrow Transplant; 2008 Jul; 42(1):43-9. PubMed ID: 18347569
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
    Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
    J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset.
    Meloni F; Salvini R; Bardoni AM; Passadore I; Solari N; Vitulo P; Oggionni T; Viganò M; Pozzi E; Fietta AM
    J Heart Lung Transplant; 2007 Nov; 26(11):1135-43. PubMed ID: 18022079
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
    Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
    Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Bronchiolitis obliterans syndrome: utility of the new guidelines in single lung transplant recipients.
    Nathan SD; Barnett SD; Wohlrab J; Burton N
    J Heart Lung Transplant; 2003 Apr; 22(4):427-32. PubMed ID: 12681420
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome.
    Brugière O; Thabut G; Mal H; Marceau A; Dauriat G; Marrash-Chahla R; Castier Y; Lesèche G; Colombat M; Fournier M
    Eur Respir J; 2005 May; 25(5):813-9. PubMed ID: 15863637
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
    Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Assessment of forced expiratory volume in one second-fraction of the engrafted lung with 133-Xe radiospirometry improves the diagnosis of bronchiolitis obliterans syndrome in single lung transplant recipients.
    Ikonen T; Harjula AL; Kinnula VL; Savola J; Sovijärvi A
    J Heart Lung Transplant; 1995; 14(2):244-50. PubMed ID: 7779842
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Organizing pneumonia following pulmonary transplantation and the development of obliterative bronchiolitis.
    Milne DS; Gascoigne AD; Ashcroft T; Sviland L; Malcolm AJ; Corris PA
    Transplantation; 1994 Jun; 57(12):1757-62. PubMed ID: 8016882
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Bronchiolitis obliterans syndrome leads to a functional deterioration of the acinus post lung transplant.
    Thompson BR; Hodgson YM; Kotsimbos T; Liakakos P; Ellis MJ; Snell GI; Verbanck S
    Thorax; 2014 May; 69(5):487-8. PubMed ID: 24212890
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.
    Hachem RR; Edwards LB; Yusen RD; Chakinala MM; Alexander Patterson G; Trulock EP
    Clin Transplant; 2008; 22(5):603-8. PubMed ID: 18435784
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Outcomes after lung transplantation in patients with chronic hepatitis C virus infection.
    Sahi H; Zein NN; Mehta AC; Blazey HC; Meyer KH; Budev M
    J Heart Lung Transplant; 2007 May; 26(5):466-71. PubMed ID: 17449415
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Jaksch P; Scheed A; Keplinger M; Ernst MB; Dani T; Just U; Nahavandi H; Klepetko W; Knobler R
    J Heart Lung Transplant; 2012 Sep; 31(9):950-7. PubMed ID: 22884382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.